February 2020

February 17, 2020 Intelligence: Late-Breaking Lab News

Last month, Tech-Crunch reported that a data breach at Laboratory Corporation of America had exposed the protected health information (PHI) of thousands of patients. TechCrunch published its findings on Jan. 28, 2020. It wrote, “This latest security lapse was caused by a vulnerability on a part of LabCorp’s website, understood to host the company’s internal […]

To access this post, you must purchase The Dark Report.

February 17, 2020 Intelligence: Late-Breaking Lab News Read More »

Judge Rules in Theranos Case, Elizabeth Holmes Again Is News

Clinical Laboratory Trends / Joseph Burns

Attorneys for former Theranos CEO Elizabeth Holmes and former President Ramesh Balwani are in court maneuvering before the federal case starts the trial phase this summer. Last week, Judge Edward J. Davila ruled that prosecutors from the federal Department of Justice (DOJ) cannot argue that physicians and insured patients were victims of fraud that Theranos

To access this post, you must purchase The Dark Report.

Judge Rules in Theranos Case, Elizabeth Holmes Again Is News Read More »

Northwell Health Labs Produce Value-Added Outcomes, Growth

Clinical Laboratory Trends / Joseph Burns

>CEO SUMMARY: In 2008, the administration at the Northwell Health system on Long Island considered selling its inpatient and outpatient laboratory services to a commercial laboratory company. In response, the leaders of the Northwell Health Laboratories proposed a plan to show how the health system would benefit clinically and financially by retaining the laboratories. Ten

To access this post, you must purchase The Dark Report.

Northwell Health Labs Produce Value-Added Outcomes, Growth Read More »

Northwell and Memorial Health: A Tale of Two Labs

Commentary and Opinion by R. Lewis Dark / R. Lewis Dark

Something very unusual happened in this issue of The Dark Report. We analyzed the entirely opposite fates of two clinical laboratories owned by different healthcare systems. With apologies to author Charles Dickens and his opening sentence in his novel, a Tale of Two Cities, it can be said that, “for one lab, it was the

To access this post, you must purchase The Dark Report.

Northwell and Memorial Health: A Tale of Two Labs Read More »

First EKRA Guilty Plea Involves Lab Kickback

Laboratory Compliance / Joseph Burns

CEO SUMMARY: Federal investigators wasted little time in using the Eliminating Kickbacks in Recovery Act of 2018 (EKRA) to prosecute fraud involving clinical laboratories and providers. The manager of an opioid treatment center in Kentucky pleaded guilty last month to three counts: soliciting a bribe, making a false statement, and attempting to tamper with evidence.

To access this post, you must purchase The Dark Report.

First EKRA Guilty Plea Involves Lab Kickback Read More »

Memorial Hermann Sells Outreach Lab to Quest

Clinical Laboratory Trends / Joseph Burns

>CEO SUMMARY: Need for more capital is probably one reason why Memorial Hermann Health System decided to sell its large clinical laboratory outreach business to Quest Diagnostics in a transaction both organizations announced on Jan. 27. Although terms of the sale were not announced, lab executives in Houston believe that Memorial Hermann will be paid

To access this post, you must purchase The Dark Report.

Memorial Hermann Sells Outreach Lab to Quest Read More »

January 27, 2020 Intelligence: Late-Breaking Lab News

Late Breaking Lab News / Robert Michel

In recent weeks, the Supreme Court declined to consider an appeal in a case which challenged a lab company’s patent on a clinical laboratory test. On Jan. 13, the justices rejected the appeal made by Athena Diagnostics, a division of Quest Diagnostics. In an earlier ruling, a lower court had ruled in favor of the

To access this post, you must purchase The Dark Report.

January 27, 2020 Intelligence: Late-Breaking Lab News Read More »

Two Collaborations: LabCorp-Thermo Fisher, Roche-Illumina

Lab Marketplace / Joseph Burns

In deals related to the pursuit of companion diagnostics, two lab companies announced collaboration deals with companies that manufacture gene-sequencing equipment. The deals were announced on consecutive days earlier this month. Financial terms were not disclosed. On Jan. 13, Roche said it formed a 15-year, non-exclusive partnership with Illumina to improve access to next-generation sequencing

To access this post, you must purchase The Dark Report.

Two Collaborations: LabCorp-Thermo Fisher, Roche-Illumina Read More »

Vanderbilt Lab Uses Predictive Medicine to Improve Care

Clinical Laboratory Trends / Joseph Burns

> CEO SUMMARY: The integrative diagnostics lab at the Vanderbilt University Medical Center aims to use sophisticated diagnostics to advance the use of precision medicine testing to improve patient care and to do so at an affordable cost. As part of these efforts, the lab staff seeks to predict how patients will metabolize medications and

To access this post, you must purchase The Dark Report.

Vanderbilt Lab Uses Predictive Medicine to Improve Care Read More »

NeoGenomics Spends $37M for Human Longevity’s Oncology Division

Laboratory Management / Joseph Burns

Once again, Neogenomics, Inc. is using an acquisition to build up its cancer-testing business. In a deal that closed on Jan. 10, the lab company acquired the Oncology Division of Human Longevity, based in San Diego. Neogenomics said it paid $37 million for the division of Human Longevity that does next-generation sequencing services for pharmaceutical

To access this post, you must purchase The Dark Report.

NeoGenomics Spends $37M for Human Longevity’s Oncology Division Read More »